Researcher

    Carine Nyalendo , Ph.D.

    carine.nyalendo.hsj@ssss.gouv.qc.ca
    Research Axis
    Immune Diseases and Cancer Axis
    Address
    CHUSJ

    Phone
    514 345-4931 7988

    Fax
    514-345-4803

    Title

    • Clinical Assistant Professor, Biochemistry and Molecular Medicine Department, University of Montreal, 2017
    • Clinical Biochemist, Division of Biochemistry, CHU Sainte-Justine, 2013

    Education

    • Clinical Biochemistry Specialist Certificate (CSPQ), 2015
    • Postdoctoral Diploma (DEPD) - Clinical Biochemistry, University of Montreal, 2013
    • Doctorate (PhD) - Biochemistry, University of Quebec at Montreal, 2009

    Research Interests

    • Cancer stem cells and matrix metalloproteases in neuroblastoma
    • Pediatric reference intervals. Member of the CALIPER team (Canadian Initiative in Pediatric Reference Intervals)
    • Reference intervals in pregnancy  (The Mother-Child Study)
    • Development, evaluation and validation analytical methods

    Research Topics

    • Clinical Biochemistry
    • Reference intervals
    • Cancer stem cells
    • Tumor invasion
    • 3D matrix
    • Metalloproteases
    • Neuroblastoma

    Career Summary

    • Head of Clinical Chemistry Department, CHU Sainte-Justine, 2015-2017
    • Clinical Lecturer, Biochemistry and Molecular Medicine Department, University of Montreal,  2015-2017

    Selected Publications

    1. Delvin E, Alos N, Rauch F, Marcil V, Morel S, Boisvert M, Lecours MA, Laverdière C, Sinnett D, Krajinovic M, Dubois J, Drouin S, Lefebvre G, Samoilenko M, Nyalendo C, Cavalier E, Levy E. (2018) Vitamin D nutritional status and bone turnover markers in childhood acute lymphoblastic leukemia survivors: A PETALE study. Clin Nutr. pii: S0261-5614(18)30069-4
    2. Belounis A, Nyalendo C, Le Gall R, Imbriglio TV, Mahma M, Teira P, Beaunoyer M, Cournoyer S, Haddad E, Vassal G, Sartelet H. (2016) Autophagy is associated with chemoresistance in neuroblastoma. BMC Cancer, 16(1):891.
    3. Liberman J, Sartelet H, Flahaut M, Mühlethaler-Mottet A, Coulon A, Nyalendo C, Vassal G, Joseph JM, Gross N. (2012) Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma. PLoS One, 7(8):e43665.
    4. Sartelet H, Imbriglio T, Nyalendo C, Haddad E, Annabi B, Duval M, Fetni R, Alexendrov L, Sinnett D, Fabre M, Vassal G. (2011) Expression of CD133 and poor outcome in neuroblastoma associated with chemoresistance mediated by AKT pathway. Histopathology, 60(7):1144-55.
    5. Sartelet H, Durrieu L, Fontaine F, Nyalendo C, Haddad E. (2012) Description of a new xenograft model of metastatic neuroblastoma using NOD/SCID/Il2rg Null (NSG) mice. In Vivo, 26(1):19-29.
    6. Nyalendo C, Sartelet H, Gingras D, Béliveau R. (2010) Inhibition of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation blocks tumor progression in mice. Anticancer Res, 30(6):1887-95.
    7. Nyalendo C, Sartelet H, Barette S, Ohta S, Gingras D, Béliveau R. (2009) Identification of phosphorylated membrane-type 1 matrix metalloproteinase in association with neuroblastoma progression. BMC Cancer, 9(1):422.
    8. Nyalendo C, Beaulieu E, Sartelet H, Michaud M, Fontaine N, Gingras D, and Béliveau R. (2008) Impaired tyrosine phosphorylation of membrane type 1-matrix metalloproteinase reduces tumor cell proliferation in three-dimensional matrices and abrogates tumor growth in mice. Carcinogenesis, 29(8): 1655–64.
    9. Nyalendo C, Michaud M, Beaulieu E, Roghi C, Murphy G, Gingras D, and Béliveau R. (2007) Src-mediated phosphorylation of membrane-type 1 matrix metalloproteinase on its residue tyrosine 573: role in endothelial and tumour cell migration. J Biol Chem, 282(21): 156690-9.
About this page
Edited by Hoffmann Maude

Created on 9/18/2014
Alert or send a suggestion
 

Every dollar counts!

Thank you for your generosity.

It's people like you that allow us to accelerate research and heal more children better every year and, as such, offer among the best healthcare in the world.

It's also possible to give by mail or by calling toll-free

1-888-235-DONS (3667)

Contact Us

514 345-4931

Légal

© 2006-2014 CHU Sainte-Justine.
All rights reserved.
Terms of Use, Confidentiality, Security

Avertissement

Les informations contenues dans le site « CHU Sainte-Justine » ne doivent pas être utilisées comme un substitut aux conseils d’un médecin dûment qualifié et autorisé ou d’un autre professionnel de la santé. Les informations fournies ici le sont à des fins exclusivement éducatives et informatives.

Consultez votre médecin si vous croyez être malade ou composez le 911 pour toute urgence médicale.

CHU Sainte-Justine